Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,427.30INR
6:21am EDT
Change (% chg)

Rs-93.25 (-3.70%)
Prev Close
Rs2,520.55
Open
Rs2,520.00
Day's High
Rs2,520.00
Day's Low
Rs2,400.00
Volume
52,391
Avg. Vol
39,584
52-wk High
Rs3,689.00
52-wk Low
Rs2,400.00

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations
8:32am EDT 

May 25 (Reuters) - Dr.Reddy's Laboratories Ltd :Says audit of formulations Srikakulum Plant unit II, Andhra Pradesh by US FDA, completed with zero observations..  Full Article

Dr.Reddy's Laboratories says USFDA approved launch of doxorubicin hydrochloride liposome injection in U.S.
Wednesday, 17 May 2017 03:15am EDT 

May 17 (Reuters) - Dr.Reddy's Laboratories Ltd :Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market.  Full Article

India's Dr.Reddy's Laboratories March-qtr consol profit rises about three-fold
Friday, 12 May 2017 03:40am EDT 

May 12 (Reuters) - Dr.Reddy's Laboratories Ltd :Consol March quarter net profit 3.38 billion rupees.Consensus forecast for March quarter consol profit was 4.27 billion rupees.Consol March quarter net sales 34.99 billion rupees.Consol net profit in March quarter last year was 1.23 billion rupees as per Ind-AS; net sales 36.95 billion rupees.Recommended final dividend of 20 rupees per share.Says "FY17 has been a challenging year due to lack of new product approvals for US market".  Full Article

Dr. Reddy's Labs launches Ezetimibe and Simvastatin tablets in U.S. market
Thursday, 27 Apr 2017 12:37am EDT 

April 27 (Reuters) - Dr.Reddy's Laboratories Ltd :Says launch of Ezetimibe and Simvastatin tablets in U.S. market.  Full Article

Dr. Reddy's Labs, Integra Lifesciences sign deal to market Duragen products in India
Monday, 27 Mar 2017 03:02am EDT 

Dr.Reddy's Laboratories Ltd : Co, Integra Lifesciences enter agreement to market, distribute Duragen plus and suturable duragen dural regeneration in India .Says to market, distribute duragen plus and suturable duragen dural renegration matrices for use in India.  Full Article

Dr Reddys says preparing response on observations received from US FDA
Tuesday, 21 Mar 2017 02:59am EDT 

Dr.Reddy's Laboratories Ltd : Clarifies on news item "US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance." .Says preparing response and will submit it to FDA.  Full Article

Cytosorbents Corp enters into a partnership with Dr. Reddy's laboratories
Thursday, 16 Mar 2017 07:00am EDT 

Cytosorbents Corp : Have entered into a partnership with Dr. Reddy's laboratories ltd for South African market . Dr. Reddy's has exclusive rights to distribute Cytosorb for intensive care, cardiac surgery, other hospital applications in South Africa . Multi-year agreement is subject to annual minimum purchases of Cytosorb to maintain exclusivity .Financial terms of this agreement have not been disclosed.  Full Article

Dr.Reddy's Labs gets form 483 with 3 observations from USFDA for audit of Miryalaguda plant
Tuesday, 21 Feb 2017 08:10am EST 

Dr.Reddy's Laboratories Ltd : Says the audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017 .Co has been issued a form 483 with three observations.  Full Article

Dr.Reddy's Labs says co not served with legal papers in matter as in Mezzion's press release
Friday, 27 Jan 2017 04:57am EST 

Dr.Reddy's Laboratories Ltd : Dr.Reddy's Laboratories clarifies on news item "Korean biotech firm Mezzion Pharma files suit against Dr Reddy's laboratories." .Dr.Reddy's Laboratories Ltd says co not been served with legal papers or process in matter as in Mezzion's press release.  Full Article

Dr. Reddy's Labs says U.S. FDA re-audit of co's plants part of "usual activity"
Thursday, 12 Jan 2017 03:13am EST 

Dr.Reddy's Laboratories Ltd : Clarifies on news item "FDA to re-audit three Dr.Reddy's labs plants" .Says believes that schedule of audit by USFDA is usual activity.  Full Article

More From Around the Web

BRIEF-Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations

* Says audit of formulations Srikakulum Plant unit II, Andhra Pradesh by US FDA, completed with zero observations. Source text - (http://bit.ly/2qnkt2M) Further company coverage: